A new long-term study conducted by researchers at the University of Saskatchewan (U of S), Canada, is aiming at providing new ways of creating and administering vaccines. It also hopes to lay the groundwork for the next generation of X-ray imaging devices, and develop new and environmentally friendly fuel alternatives.
In this regards, the University of Saskatchewan was awarded 4.76 million dollars over seven years for three Canada Research Chairs (CRC) and associated equipment.
"This investment in these outstanding researchers will not only help develop solutions for pressing national problems in the health and energy sectors, but will increase training opportunities for graduate students and other research personnel, thereby building superb research talent for the future in areas of U of S strength," said U of S vice-president research Karen Chad.
Few of today's vaccines are effective in controlling intestinal and respiratory infections during the neonatal period (first month after birth). In some cases, these infections can cause lifelong disease.
Philip Griebel, a scientist at the U of S Vaccine and Infectious Disease Organization-International Vaccine Centre and professor in the School of Public Health, aims to identify vaccine strategies that will prevent or clear these viral or bacterial infections.
His findings will benefit both animal and human health.
Griebel's research program will encompass both creation of targeted vaccines and needle-free delivery (for example, oral vaccines) against pathogens which enter the body through mucosal surfaces such as those found in the respiratory and intestinal tracts.